Updated results from the KATHERINE trial showed that adjuvant T-DM1 provided a significant improvement in overall survival and no evidence of long-term safety issues.

Per- and polyfluoroalkyl substances (PFAS) in drinking water is associated with cancer incidence, a new study suggests.

(HealthDay News) — The US Centers for Disease Control and Prevention (CDC) recently confirmed another case of avian influenza A (H5N1), or bird flu, in a person in California, bringing the nationwide ...

Caroline Wagner is a professor of public affairs at The Ohio State University. She receives funding from SECURE, a research security service funded by the National Science Foundat ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

Monica M. Bertagnolli, MD, has decided to resign her post as director of the NIH just 14 months after she took the position.

The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

Our findings highlight divergent trends, such as the global reduction in tobacco-associated mortality but rising mortality linked to ambient particulate matter,” researchers wrote.

Oncologist Thomas C. Weiner misdiagnosed Anthony Olson with MDS in 2011. Olson is one of many patients who may have received unnecessary and harmful treatments after being misdiagnosed by Weiner.

The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...

The ASIR (per 100,000 person-years) of testicular germ cell tumors increased from 4.71 in 1992 to 6.22 in 2021, for an average annual percent change (AAPC) of 0.92%. The ASIR of seminoma increased ...